David Saussy is the Head of Licensing and Business Development for Imbrium Therapeutics. He has spent the past 24 years cultivating partnerships and executing strategic alliances for GSK, Stiefel Labs, Purdue Pharma, and Imbrium, completing deals ranging from multitarget pre-clinical collaborations to $1BN+ company acquisitions. Prior to transitioning into Licensing and Business Development, David spent 12 years in discovery research in immuno-inflammation, cardiovascular, metabolic, and genitourinary disease at Eli Lilly and Glaxo/GlaxoWellcome.